CD69 and small cell lung carcinoma: According to our data, the number of activated CD3+CD8+CD69+ T-lymphocytes, proliferating CD3+CD8+CD69+Ki67+ T-lymphocytes, and CD3+CD8+CD69+Axl+ T-lymphocytes is decreased in patients with SCLC compared with healthy volunteers (Figure 5).